<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>AMYL NITRITE - amyl nitrite inhalant </strong><br>James Alexander Corporation<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Drug Facts</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>Description: Amyl nitrite is a rapidly  acting vasodilator administered by inhalation.  0.3 ml is supplied in a covered thin glass capsule which is easily crushed between the fingers.  Amyl nitrite is a clear, yellowish liquid having a peculiar ethereal, fruity odor.  It is volatile, even at low temperatures, and is flammable.  This product is stabilized with Flexol(tm) 2 percent. The structural formula of amyl nitrite is:<div class="Figure"><img alt="package insert" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e&amp;name=amylnitriteinsert-04.jpg"></div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-1.1"></a><p></p>
<p class="First"><a href="#section-"></a></p>Amyl nitrite causes a non specific relaxation of smooth muscle with the most prominent actions occurring in vascular smooth muscle.  This effect on vascular smooth muscle results in coronary vasodilation and decreased systemic <span class="product-label-link" type="condition" conceptid="4089490" conceptname="Vascular resistance">vascular resistance</span> and left ventricular preload and afterload.  <span class="product-label-link" type="condition" conceptid="4124683" conceptname="Silent myocardial ischemia">Myocardial ischemia</span> is relieved in patients with <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">angina pectoris</span>, with an abatement of <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span> and possibly other related symptons. Amyl nitrite vapors are absorbed rapidly through the pulmonary alveoli, manifesting therapeutic effects within one minute after inhalation.  The drug is metabolized rapidly, probably by hydrolytic denitration; approximately one-third of the inhaled amyl nitrite is excreted in the urine.<br>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-1.2"></a><p></p>
<p class="First">Amyl nitrite is indicated for the rapid relief of <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">angina pectoris</span>.  Its effect appears within 30 seconds and lasts for approximately 3 to 5 minutes.<br></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-1.3"></a><p></p>
<p class="First">Since it may increase intraocular and intracranial pressures, amyl nitrite is contraindicated or should be used with great caution in patients with <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, recent head <span class="product-label-link" type="condition" conceptid="433633" conceptname="Late effect of superficial injury">trauma</span> or <span class="product-label-link" type="condition" conceptid="376713" conceptname="Cerebral hemorrhage">cerebral hemorrhage</span>.  Amyl nitrite can cause harm to the fetus when it is administered to a pregnant woman because it significantly reduces systemic blood pressure and blood flow on the maternal side of the placenta.<br></p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-1.4"></a><p></p>
<p class="First">Transient episodes of <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, or <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span> or other signs of <span class="product-label-link" type="condition" conceptid="374384" conceptname="Cerebral ischemia">cerebral ischemia</span> due to <span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">postural hypotension</span> may develop following inhalation of amyl nitrite, particularly if the patient is standing immobile.  To hasten recovery, measures which facilitate venous return such as head low posture, deep breathing and movement of extremities may be used.<br></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-1.5"></a><p></p>
<p class="First">Amyl nitrite is very flammable.  Do not use where it might become ignited.  General - Tolerance to amyl nitrite may develop with repeated use of the drug for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span> of time.  Tolerance may be minimized by beginning with the smallest effective dose and alternating the drug with another coronary vasodilator.  High doses of nitrites may produce <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">methemoglobinemia</span>, especially in individuals with methemoglobin reductase deficiency or other metabolic abnormality that interferes with the normal conversion of methemoglobin back to hemoglobin. Patient Information - Amyl nitrite should be taken by the patient when seated or lying down. Drug Interactions - Taking amyl nitrite after drinking alcohol may worsen side effects and may cause severe <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> and <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">cardiovascular collapse</span>.  Carcinogenesis, Mutagenesis, Fertility Impairment - Adequate long term studies to establish adverse carcinogenic potential of this drug have not been reported. Pregnancy - Teratogenic effects. Category C. Animal studies have not been conducted with amyl nitrite.  It is also not known whether amyl nitrite can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Amyl nitrite should be given to a pregnant woman only if clearly needed. Nursing Mothers - It is not known whether this drug is excreted in human milk.  Because many drugs are excreted in human milk, caution should be exercised when amyl nitrite is administered to a nursing woman. Pediatric Use - Safety and effectiveness in children have not been established.<br></p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-1.6"></a><p></p>
<p class="First">Mild transitory <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span> and <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> of the face are common with the use of amyl nitrite.  The following adverse reactions may occur in susceptible patients <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>, involuntary passing of urine and feces, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>, <span class="product-label-link" type="condition" conceptid="4308436" conceptname="Cold sweat">cold sweat</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>.  Excessively high doses of amyl nitrite administered chronically may cause <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">methemoglobinemia</span>.<br></p>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="section-1.7"></a><p></p>
<p class="First">Abuse. Volatile nitrites are abused for sexual stimulation, with <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> as a common side effect. <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">Dependence</span>. Tolerance to nitrites can develop conditions and duration have not been established.<br></p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-1.8"></a><p></p>
<p class="First">Symptons. Inhaled doses of 5 to 10 drops of amyl nitrite may cause violent <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> of the face, accompanied by a feeling of imminent bursting of the head and very excessive heart action. The inhalation of larger amounts may produce a feeling of <span class="product-label-link" type="condition" conceptid="4139960" conceptname="Strangulation">suffocation</span> and <span class="product-label-link" type="condition" conceptid="79908" conceptname="Muscle weakness">muscular weakness</span>. Symptons comparable to <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> may be produced such as <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span> <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span> <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span> <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> snycope and <span class="product-label-link" type="condition" conceptid="444035" conceptname="Incontinence">incontinence</span> attributable to pooling of blood in the postarteriolar vessels and failure of the venous blood to return to the heart.  Treatment. Measures which facilitate venous return such as head low posture, deep breathing and movement of extremities may be used. The use of epinephrine aggravates the <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> like reaction. Methylene blue should be injected for treatment of severe <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">methemoglobinemia</span> with <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>. For treating cyanide <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">poisoning</span>, methylene blue is contraindicated where nitrites cause iatrogenic <span class="product-label-link" type="condition" conceptid="432882" conceptname="Methemoglobinemia">methemoglobinemia</span>.<br></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-1.9"></a><p></p>
<p class="First">With the patient in recumbent or seated position a capsule of amyl nitrite is held away from the face, crushed between the fingers, and held under the patient's nose. Two to six inhalations of the vapors from the capsule are usually sufficient to promptly produce therapeutic effects. Caution is recommended to avoid inhalation of excessive amounts of the drug when it is administered by someone other than the patient. If necessary, the dose may be repeated in 3 to 5 minutes.<br></p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-1.10"></a><p></p>
<p class="First">James Alexander brand amyl nitrite is furnished in covered glass capsules. Each capsule contains 0.3 ml in boxes of 12. The capsule contents are flammable and should be protected from light. Storage should be in a <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span> place. 2 - 8 C 36 to 46 F. The James Alexander Corporation Blairstown, NJ 07825.<br></p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-2"></a><p></p>
<p class="First">Amyl Nitrite Inhalants, USP each ampule contains 0.3 ml For Inhalation Only A rapidly acting vasodilator used for <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">angina pectoris</span>. Directions. Crush a covered ampule between fingers held away from the face. Hold to nostrils and carefully inhale vapor.<img alt="amyl nitrite inner label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e&amp;name=amylnitriteinnerlabel-01.jpg"></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-3"></a><p></p>
<p class="First">Keep away from open flame or spark 12 boxes each containing 12 crushable ampules with protective covering Amyl Nitrite Inhalants USP Each ampule contains 0.3 ml for inhalation only store in a <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span> place between 2C and 8C Keep out of reach of children.<img alt="amyl nitrite outer label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e&amp;name=amylnitriteouterlabel-02.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>AMYL NITRITE 		
					</strong><br><span class="contentTableReg">amyl nitrite inhalant</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:46414-2222</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">RESPIRATORY (INHALATION)</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Amyl Nitrite</strong> (Amyl Nitrite) </td>
<td class="formItem">Amyl Nitrite</td>
<td class="formItem">0.3 g  in 0.3 mL</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:46414-2222-8</td>
<td class="formItem">144  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:46414-2222-1</td>
<td class="formItem">0.3 mL in 1 AMPULE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">02/07/1979</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>James Alexander Corporation
							(040756421)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>James Alexander Corporation (040756421)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">James Alexander Corporation</td>
<td class="formItem"></td>
<td class="formItem">040756421</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>ae50aae0-d07f-4096-b009-bf424a00f0b5</div>
<div>Set id: c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e</div>
<div>Version: 1</div>
<div>Effective Time: 20100721</div>
</div>
</div> <div class="DistributorName">James Alexander Corporation</div></p>
</body></html>
